Impact of COVID-19 in patients with autoimmune bullous
diseases: Report from an international registry.

J 2023

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

MEIJER, Joost M, Hanan RASHID, Styliani VERGADI, Emiliano ANTIGA, Pamela VEZZOLI et. al.

Basic information

Original name

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

Authors

MEIJER, Joost M, Hanan RASHID, Styliani VERGADI, Emiliano ANTIGA, Pamela VEZZOLI, Riccardo BALESTRI, Aikaterini PATSATSI, Soner UZUN, Dusan SKILJEVIC, Hana JEDLIČKOVÁ (203 Czech Republic, belonging to the institution), Lucia VOJTĚCHOVÁ (703 Slovakia, belonging to the institution), Alberto CORRÀ, Alessandra PONZIANI, Claudia GÜNTHER, Giuseppe CIANCHINI, Matthias SCHEFZYK, Angelo MARZANO, Di Zenzo GIOVANNI, Iakov SHIMANOVICH, Janet FAIRLEY, Jose M MASCARÓ, Marzia CAPRONI, Roberto MAGLIE, Enno SCHMIDT and Barbara HORVÁTH

Edition

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, HOBOKEN, WILEY, 2023, 0926-9959

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30216 Dermatology and venereal diseases

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 9.200 in 2022

RIV identification code

RIV/00216224:14110/23:00132899

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1111/jdv.19242

UT WoS

001016217900001

Keywords in English

COVID-19; autoimmune bullous diseases

Abstract

V originále

For autoimmune bullous diseases (AIBD) such as bullous pemphigoid (BP) and pemphigus an increased risk of COVID-19 infection and mortality was reported, with oral prednisolone (dose ≥10 mg/day) and treatment of rituximab being a risk factor. A population-based cohort study showed an increased COVID-19 associated mortality in patients with BP, but not in patients with pemphigus vulgaris. Here, we provide the findings of an international registry for health care providers about COVID-19 infection in patients with AIBD, reporting on timing and clinical presentation of COVID-19 infection, AIBD disease activity and outcome.

Citovat

MEIJER, Joost M, Hanan RASHID, Styliani VERGADI, Emiliano ANTIGA, Pamela VEZZOLI, Riccardo BALESTRI, Aikaterini PATSATSI, Soner UZUN, Dusan SKILJEVIC, Hana JEDLIČKOVÁ, Lucia VOJTĚCHOVÁ, Alberto CORRÀ, Alessandra PONZIANI, Claudia GÜNTHER, Giuseppe CIANCHINI, Matthias SCHEFZYK, Angelo MARZANO, Di Zenzo GIOVANNI, Iakov SHIMANOVICH, Janet FAIRLEY, Jose M MASCARÓ, Marzia CAPRONI, Roberto MAGLIE, Enno SCHMIDT and Barbara HORVÁTH. Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. HOBOKEN: WILEY, 2023, vol. 37, No 10, p. "e1189"-"e1191", 3 pp. ISSN 0926-9959. Available from: https://dx.doi.org/10.1111/jdv.19242.

@article{2358800,
   author = {Meijer, Joost M and Rashid, Hanan and Vergadi, Styliani and Antiga, Emiliano and Vezzoli, Pamela and Balestri, Riccardo and Patsatsi, Aikaterini and Uzun, Soner and Skiljevic, Dusan and Jedličková, Hana and Vojtěchová, Lucia and Corrà, Alberto and Ponziani, Alessandra and Günther, Claudia and Cianchini, Giuseppe and Schefzyk, Matthias and Marzano, Angelo and Giovanni, Di Zenzo and Shimanovich, Iakov and Fairley, Janet and Mascaró, Jose M and Caproni, Marzia and Maglie, Roberto and Schmidt, Enno and Horváth, Barbara},
   article_location = {HOBOKEN},
   article_number = {10},
   doi = {http://dx.doi.org/10.1111/jdv.19242},
   keywords = {COVID-19; autoimmune bullous diseases},
   language = {eng},
   issn = {0926-9959},
   journal = {JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY},
   title = {Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.},
   url = {https://onlinelibrary.wiley.com/doi/10.1111/jdv.19242},
   volume = {37},
   year = {2023}
}

TY  - JOUR
ID  - 2358800
AU  - Meijer, Joost M - Rashid, Hanan - Vergadi, Styliani - Antiga, Emiliano - Vezzoli, Pamela - Balestri, Riccardo - Patsatsi, Aikaterini - Uzun, Soner - Skiljevic, Dusan - Jedličková, Hana - Vojtěchová, Lucia - Corrà, Alberto - Ponziani, Alessandra - Günther, Claudia - Cianchini, Giuseppe - Schefzyk, Matthias - Marzano, Angelo - Giovanni, Di Zenzo - Shimanovich, Iakov - Fairley, Janet - Mascaró, Jose M - Caproni, Marzia - Maglie, Roberto - Schmidt, Enno - Horváth, Barbara
PY  - 2023
TI  - Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.
JF  - JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
VL  - 37
IS  - 10
SP  - "e1189"-"e1191"
EP  - "e1189"-"e1191"
PB  - WILEY
SN  - 09269959
KW  - COVID-19
KW  - autoimmune bullous diseases
UR  - https://onlinelibrary.wiley.com/doi/10.1111/jdv.19242
N2  - For autoimmune bullous diseases (AIBD) such as bullous pemphigoid (BP) and pemphigus an increased risk of COVID-19 infection and mortality was reported, with oral prednisolone (dose ≥10 mg/day) and treatment of rituximab being a risk factor. A population-based cohort study showed an increased COVID-19 associated mortality in patients with BP, but not in patients with pemphigus vulgaris. Here, we provide the findings of an international registry for health care providers about COVID-19 infection in patients with AIBD, reporting on timing and clinical presentation of COVID-19 infection, AIBD disease activity and outcome.
ER  -

MEIJER, Joost M, Hanan RASHID, Styliani VERGADI, Emiliano ANTIGA, Pamela VEZZOLI, Riccardo BALESTRI, Aikaterini PATSATSI, Soner UZUN, Dusan SKILJEVIC, Hana JEDLIČKOVÁ, Lucia VOJTĚCHOVÁ, Alberto CORRÀ, Alessandra PONZIANI, Claudia GÜNTHER, Giuseppe CIANCHINI, Matthias SCHEFZYK, Angelo MARZANO, Di Zenzo GIOVANNI, Iakov SHIMANOVICH, Janet FAIRLEY, Jose M MASCARÓ, Marzia CAPRONI, Roberto MAGLIE, Enno SCHMIDT and Barbara HORVÁTH. Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry. \textit{JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY}. HOBOKEN: WILEY, 2023, vol.~37, No~10, p.~''e1189''-''e1191'', 3 pp. ISSN~0926-9959. Available from: https://dx.doi.org/10.1111/jdv.19242.

Detailed Information on Publication Record